BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 24375061)

  • 1. IL-17 and IL-4 producing CD8+ T cells in tumor draining lymph nodes of breast cancer patients: positive association with tumor progression.
    Faghih Z; Rezaeifard S; Safaei A; Ghaderi A; Erfani N
    Iran J Immunol; 2013 Dec; 10(4):193-204. PubMed ID: 24375061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD8+ T Lymphocyte Subsets in Bladder Tumor Draining Lymph Nodes.
    Faghih Z; Shobeiri SS; Ariafar A; Sarkarian M; Zeighami S; Nazari N; Abbasi-Sarvak S; Erfani N
    Iran J Immunol; 2016 Dec; 13(4):237-248. PubMed ID: 27999236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-17/IFN-γ double producing CD8+ T (Tc17/IFN-γ) cells: a novel cytotoxic T-cell subset converted from Tc17 cells by IL-12.
    Tajima M; Wakita D; Satoh T; Kitamura H; Nishimura T
    Int Immunol; 2011 Dec; 23(12):751-9. PubMed ID: 22039016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune profiles of CD4+ lymphocyte subsets in breast cancer tumor draining lymph nodes.
    Faghih Z; Erfani N; Haghshenas MR; Safaei A; Talei AR; Ghaderi A
    Immunol Lett; 2014; 158(1-2):57-65. PubMed ID: 24326038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
    Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
    Berner B; Akça D; Jung T; Muller GA; Reuss-Borst MA
    J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric analysis of circulating dendritic cell subsets and intracellular cytokine production in advanced breast cancer patients.
    Ferrari S; Malugani F; Rovati B; Porta C; Riccardi A; Danova M
    Oncol Rep; 2005 Jul; 14(1):113-20. PubMed ID: 15944777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression and costimulatory effect of 4-1BB (CD137) and CD28 molecules on cytokine-induced murine CD8(+) Tc1 and Tc2 cells.
    Vinay DS; Kwon BS
    Cell Immunol; 1999 Feb; 192(1):63-71. PubMed ID: 10066348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe atopic dermatitis is characterized by selective expansion of circulating TH2/TC2 and TH22/TC22, but not TH17/TC17, cells within the skin-homing T-cell population.
    Czarnowicki T; Gonzalez J; Shemer A; Malajian D; Xu H; Zheng X; Khattri S; Gilleaudeau P; Sullivan-Whalen M; Suárez-Fariñas M; Krueger JG; Guttman-Yassky E
    J Allergy Clin Immunol; 2015 Jul; 136(1):104-115.e7. PubMed ID: 25748064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of cells from a non-invaded and an invaded lymph node with a HER-2+ tumor with peptides corresponding to T-cell epitopes E75 and G89 induced expansion of central memory cells (TCM) from the metastasis-negative lymph nodes.
    Ko BK; Efferson CL; Kawano K; Kuerer HM; Sahin A; Murray JL; Ioannides CG
    Int J Oncol; 2004 Jun; 24(6):1413-8. PubMed ID: 15138582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effects of tumor-reactive type 1 and type 2 CD8+ T cell subpopulations in established pulmonary metastases.
    Dobrzanski MJ; Reome JB; Dutton RW
    J Immunol; 1999 Jun; 162(11):6671-80. PubMed ID: 10352285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of adoptively transferred CD8 T cells and host cells in the control of the growth of the EG7 thymoma: factors that determine the relative effectiveness and homing properties of Tc1 and Tc2 effectors.
    Helmich BK; Dutton RW
    J Immunol; 2001 Jun; 166(11):6500-8. PubMed ID: 11359800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships between regulatory T cells and CD8+ effector populations in patients with squamous cell carcinoma of the head and neck.
    Chikamatsu K; Sakakura K; Whiteside TL; Furuya N
    Head Neck; 2007 Feb; 29(2):120-7. PubMed ID: 17103408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of a CD4
    Jafarinia M; Mehdipour F; Hosseini SV; Ghahramani L; Hosseinzadeh M; Ghaderi A
    Tumour Biol; 2016 Nov; 37(11):14659-14666. PubMed ID: 27619682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative and qualitative analysis of the balance between type 1 and type 2 cytokine-producing CD8(-) and CD8(+) T cells in systemic lupus erythematosus.
    Amel-Kashipaz MR; Huggins ML; Lanyon P; Robins A; Todd I; Powell RJ
    J Autoimmun; 2001 Sep; 17(2):155-63. PubMed ID: 11591124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allergen immunotherapy in intermittent allergic rhinitis reduces the intracellular expression of IL-4 by CD8+ T cells.
    Glück J; Rogala B; Rogala E; Oleś E
    Vaccine; 2007 Dec; 26(1):77-81. PubMed ID: 18054415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum cytokine levels and type 1 and type 2 intracellular T cell cytokine profiles in mixed connective tissue disease.
    Bodolay E; Aleksza M; Antal-Szalmás P; Végh J; Szodoray P; Soltész P; Szegedi A; Szekanecz Z
    J Rheumatol; 2002 Oct; 29(10):2136-42. PubMed ID: 12375323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD8(+) T cells with distinct cytokine-producing features and low cytotoxic activity in eosinophilic and non-eosinophilic chronic rhinosinusitis with nasal polyps.
    Ma J; Shi LL; Deng YK; Wang H; Cao PP; Long XB; Zhang XH; Liu Y; Zeng M; Liu Z
    Clin Exp Allergy; 2016 Sep; 46(9):1162-75. PubMed ID: 27176491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic regulation of effector IFN-γ-producing and IL-17-producing T cell subsets in the development of acute graft-versus-host disease.
    Zhao K; Ruan S; Yin L; Zhao D; Chen C; Pan B; Zeng L; Li Z; Xu K
    Mol Med Rep; 2016 Feb; 13(2):1395-403. PubMed ID: 26647759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8-mediated type 1 antitumor responses selectively modulate endogenous differentiated and nondifferentiated T cell localization, activation, and function in progressive breast cancer.
    Dobrzanski MJ; Reome JB; Hylind JC; Rewers-Felkins KA
    J Immunol; 2006 Dec; 177(11):8191-201. PubMed ID: 17114496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.